President hails developers of COVID-19 treatment based on Chinese medicine

  • By Su Yung-yao and Jonathan Chin / Personal Reporter, with a personal editor

President Tsai Ing-wen (蔡英文) yesterday praised traditional Chinese medicine doctors who participated in the National Research Institute of Chinese Medicine-led development of the herbal formula NRICM101, which is used to treat COVID-19.

Tsai said during a meeting with representatives of the National Union of Chinese Medical Associations at the presidential office that practitioners should be recognized for their contributions in the fight against the COVID-19 pandemic.

A study published in the journal Biomedicine and Pharmacotherapy in January showed the treatment was effective against the virus.

Photo: Chiu Chih-jou, Taipei Times

NRICM101 shows that combining traditional Chinese medicine with scientific methods can lead to new therapeutic possibilities, she said.

The formula’s makers have secured licenses to export the drug, which would help the global effort to treat COVID-19 patients, she said, adding that an improved formula is currently being tested in medical facilities. clinical tests.

Tsai thanked union general secretary Ko Fu-yang (柯富揚), saying he had played an important role in guiding and organizing the effort.

In recent years, the government has sought to expand medical services that use traditional Chinese medicine, she said.

These efforts include pilot programs that expand national health insurance coverage for traditional Chinese medicine treatments for cancer and other acute conditions, as well as its use in home care, she said.

The government will continue to work with traditional Chinese medicine practitioners and researchers to develop the field and combat the pandemic, she said.

“Only by working together can the country move forward and overcome the many challenges ahead,” she said.

Comments will be moderated. Keep comments relevant to the article. Remarks containing abusive and obscene language, personal attacks of any kind or promotion will be removed and the user banned. The final decision will be at the discretion of The Taipei Times.